US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.33

-1.0900-8.78%

Post-market: 11.400.0700+0.62%19:30 EDT

Volume:299.63K

Turnover:3.40M

Market Cap:3.84B

PE:-536.97

High:11.39

Open:11.34

Low:11.19

Close:12.42

52wk High:12.60

52wk Low:6.28

Shares:339.00M

Float Shares:272.00M

Volume Ratio:2.20

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0211

EPS(LYR):-0.0211

ROE:7.36%

ROA:2.71%

PB:7.88

PE(LYR):-536.97

Loading ...

Overview Company News Filings

Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)

Telix Pharmaceuticals Posts Higher Q2 Revenue

MT Newswires Live

Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

RBC Downgrades Telix Pharmaceuticals to Sector Perform From Outperform, Keeps AU$18 Price Target

MT Newswires Live

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.

Telix Pharmaceuticals Completes Phase Three Enrollment for Prostate Cancer Imaging Study in Japan

MT Newswires Live

Telix Pharmaceuticals Opens Radiopharmaceutical Research, Manufacturing, Treatment Facility in Melbourne

MT Newswires Live

3 ASX Growth Stocks Backed By Insiders That Could Reward Patient Investors

Simply Wall St.

Telix Reports First Patients Dosing in Prostate Cancer Trial

MT Newswires Live

Citi Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)

Citi Sees Positive Catalysts for Telix Pharmaceuticals

3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks

Simply Wall St.

Telix Stock And Two ASX Growth Picks Backed By Insider Ownership

Simply Wall St.

3 Fast Growing ASX Stocks With High Insider Ownership to Watch

Simply Wall St.

Telix trims potential dilution as conditional share rights lapse

Telix Pharmaceuticals Issues New Shares After Conversion of Unquoted Securities

Telix Seeks ASX Quotation for Additional Ordinary Shares

Fast Growing Australian Stocks Where Insider Ownership Signals Real Skin In The Game

Simply Wall St.

Champion Iron Stock And 2 Fast Growing Insider Owned Picks

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TLX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":11.33,"timestamp":1787342400000,"preClose":12.42,"halted":0,"volume":299625,"hourTrading":{"tag":"盘后","latestPrice":11.4,"preClose":11.33,"latestTime":"19:30 EDT","volume":497,"amount":5666.12,"timestamp":1787355007152,"change":0.07,"changeRate":0.006178,"amplitude":0.006178},"delay":0,"changeRate":-0.08776167471819644,"floatShares":272000000,"shares":339000000,"eps":-0.0211,"marketStatus":"Market Closed","change":-1.09,"latestTime":"08-21 16:00:00 EDT","open":11.34,"high":11.39,"low":11.19,"amount":3395453.5710000005,"amplitude":0.016103,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0211,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":12.42,"preHourTrading":{"tag":"盘前","latestPrice":11.3,"preClose":12.42,"latestTime":"09:29 EDT","volume":9930,"amount":113052.21588,"timestamp":1787318999999,"change":-1.12,"changeRate":-0.090177,"amplitude":0.02818},"postHourTrading":{"tag":"盘后","latestPrice":11.4,"preClose":11.33,"latestTime":"19:30 EDT","volume":497,"amount":5666.12,"timestamp":1787355007152,"change":0.07,"changeRate":0.006178,"amplitude":0.006178},"volumeRatio":2.1988469508579978},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":272000000,"roa":"2.71%","roe":"7.36%","lyrEps":-0.0211,"volumeRatio":2.1988469508579978,"shares":339000000,"dividePrice":0,"high":11.39,"amplitude":0.016103,"preClose":12.42,"low":11.19,"week52Low":6.28,"pbRate":"7.88","psRate":"4.31","week52High":12.5999,"institutionHeld":0,"latestPrice":11.33,"eps":-0.0211,"divideRate":0,"volume":299625,"delay":0,"ttmEps":-0.0211,"open":11.34,"prevYearClose":7.49,"prevWeekClose":11.82,"prevMonthClose":9.89,"prevQuarterClose":11.53,"fiveDayClose":11.82,"twentyDayClose":10.22,"sixtyDayClose":9.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"TLX","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1758254400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2026-08-21","current":-536.966825,"percent":0.281179,"low":-584.49693,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"high":383.853933,"avg":21.978205,"sd":314.696392,"marketCap":3778875522.96},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-08","current":119.575098,"twenty":163.364827,"median":173.121803,"eighty":185.031841,"marketCap":3879545892.37},{"date":"2025-08-15","current":118.626089,"twenty":162.985468,"median":172.816584,"eighty":184.520886,"marketCap":3844757658.1},{"date":"2025-08-22","current":367.342977,"twenty":162.565192,"median":172.783145,"eighty":185.031841,"marketCap":3983594342.69},{"date":"2025-08-29","current":297.28853,"twenty":162.917681,"median":173.086118,"eighty":186.439488,"marketCap":3223899680.91},{"date":"2025-09-05","current":280.194275,"twenty":162.97191,"median":173.155042,"eighty":187.353158,"marketCap":3038523660.62},{"date":"2025-09-12","current":284.24913,"twenty":163.053254,"median":173.392729,"eighty":189.722035,"marketCap":3082495919.22},{"date":"2025-09-19","current":299.993591,"twenty":163.181765,"median":173.840405,"eighty":192.411646,"marketCap":3253234303.96},{"date":"2025-09-26","current":303.368871,"twenty":163.269039,"median":174.34097,"eighty":195.332201,"marketCap":3289837005.56},{"date":"2025-10-03","current":316.222238,"twenty":163.331056,"median":174.844246,"eighty":197.182743,"marketCap":3429223360.77},{"date":"2025-10-10","current":308.943311,"twenty":163.584606,"median":175.579785,"eighty":198.432664,"marketCap":3350288154.24},{"date":"2025-10-17","current":337.724829,"twenty":164.112905,"median":175.99796,"eighty":200.117317,"marketCap":3662404902.51},{"date":"2025-10-24","current":335.676999,"twenty":164.422238,"median":176.508379,"eighty":204.373856,"marketCap":3640197520.67},{"date":"2025-10-31","current":328.898919,"twenty":164.871944,"median":177.318176,"eighty":280.077091,"marketCap":3566693671.28},{"date":"2025-11-07","current":302.845362,"twenty":165.230483,"median":178.059203,"eighty":285.744085,"marketCap":3284159889.46},{"date":"2025-11-14","current":289.051675,"twenty":165.371547,"median":178.295984,"eighty":290.299055,"marketCap":3134576370.19},{"date":"2025-11-21","current":278.19044,"twenty":165.561349,"median":179.014446,"eighty":289.541689,"marketCap":3016793389.39},{"date":"2025-11-28","current":310.533522,"twenty":165.669807,"median":179.412236,"eighty":291.060611,"marketCap":3367532955.32},{"date":"2025-12-05","current":306.208941,"twenty":165.670741,"median":180.00406,"eighty":294.691227,"marketCap":3320635708.33},{"date":"2025-12-12","current":286.055209,"twenty":165.873166,"median":180.584513,"eighty":295.905706,"marketCap":3102081667.78},{"date":"2025-12-19","current":244.707348,"twenty":165.940952,"median":181.091444,"eighty":294.691227,"marketCap":2653691145.03},{"date":"2025-12-26","current":248.848958,"twenty":166.394684,"median":181.60348,"eighty":294.390689,"marketCap":2698604201.29},{"date":"2026-01-02","current":236.757004,"twenty":166.574536,"median":182.507221,"eighty":293.840477,"marketCap":2567474872.89},{"date":"2026-01-09","current":234.880062,"twenty":166.797362,"median":182.734458,"eighty":292.111558,"marketCap":2547120662.92},{"date":"2026-01-16","current":240.619616,"twenty":166.998047,"median":183.212494,"eighty":291.104403,"marketCap":2609362374.53},{"date":"2026-01-23","current":233.793317,"twenty":167.188576,"median":183.578507,"eighty":290.823686,"marketCap":2535335622.99},{"date":"2026-01-30","current":230.611959,"twenty":167.428163,"median":183.988776,"eighty":290.419247,"marketCap":2500835870.83},{"date":"2026-02-06","current":214.320895,"twenty":167.500324,"median":184.979028,"eighty":290.056234,"marketCap":2324169939.4},{"date":"2026-02-13","current":194.105832,"twenty":167.571527,"median":185.74722,"eighty":289.461299,"marketCap":2104950801.53},{"date":"2026-02-20","current":-349.931165,"twenty":167.550165,"median":186.245055,"eighty":289.186438,"marketCap":2493259551.93},{"date":"2026-02-27","current":-337.576812,"twenty":166.94361,"median":185.358176,"eighty":288.884688,"marketCap":2405234781.68},{"date":"2026-03-06","current":-357.014534,"twenty":165.886723,"median":184.229774,"eighty":287.796958,"marketCap":2543728559.75},{"date":"2026-03-13","current":-380.87359,"twenty":165.371547,"median":183.661424,"eighty":286.105301,"marketCap":2713724328.68},{"date":"2026-03-20","current":-427.441295,"twenty":164.112905,"median":183.427298,"eighty":285.888656,"marketCap":3045519229.47},{"date":"2026-03-27","current":-448.04178,"twenty":163.181765,"median":182.800475,"eighty":285.212188,"marketCap":3192297684.03},{"date":"2026-04-02","current":-425.435204,"twenty":162.890567,"median":182.629922,"eighty":285.17117,"marketCap":3031225831.43},{"date":"2026-04-10","current":-492.382264,"twenty":161.467054,"median":181.810223,"eighty":284.24913,"marketCap":3508223631.57},{"date":"2026-04-17","current":-499.465833,"twenty":158.955031,"median":181.091444,"eighty":284.07528,"marketCap":3558694058.36},{"date":"2026-04-24","current":-507.89561,"twenty":156.233199,"median":180.584513,"eighty":282.031139,"marketCap":3618756217.23},{"date":"2026-05-01","current":-532.518745,"twenty":154.872282,"median":180.00406,"eighty":281.147736,"marketCap":3794196059.21},{"date":"2026-05-08","current":-508.824558,"twenty":144.045965,"median":179.412236,"eighty":280.966174,"marketCap":3625374971.37},{"date":"2026-05-15","current":-506.065728,"twenty":140.182144,"median":178.86094,"eighty":280.209239,"marketCap":3605718311.9},{"date":"2026-05-22","current":-452.537308,"twenty":125.947014,"median":178.262158,"eighty":280.194275,"marketCap":3224328322.29},{"date":"2026-05-29","current":-444.681415,"twenty":120.122064,"median":178.059203,"eighty":279.725537,"marketCap":3168355079.47},{"date":"2026-06-05","current":-452.683664,"twenty":115.968865,"median":177.318176,"eighty":279.589795,"marketCap":3225371110.32},{"date":"2026-06-12","current":-453.131496,"twenty":29.784924,"median":176.508379,"eighty":278.469383,"marketCap":3228561906.13},{"date":"2026-06-18","current":-479.232706,"twenty":-319.885885,"median":176.029393,"eighty":275.361846,"marketCap":3414533028.17},{"date":"2026-06-26","current":-505.22407,"twenty":-336.088027,"median":175.625224,"eighty":265.637187,"marketCap":3599721496.58},{"date":"2026-07-02","current":-567.292731,"twenty":-347.690038,"median":175.082406,"eighty":259.576863,"marketCap":4041960704.33},{"date":"2026-07-10","current":-538.02731,"twenty":-371.335373,"median":174.480785,"eighty":256.751103,"marketCap":3833444584.84},{"date":"2026-07-17","current":-497.824928,"twenty":-406.861587,"median":173.909122,"eighty":252.484997,"marketCap":3547002606.6},{"date":"2026-07-24","current":-487.362208,"twenty":-419.925535,"median":173.731386,"eighty":249.449835,"marketCap":3472455733.71},{"date":"2026-07-31","current":-475.018244,"twenty":-425.317007,"median":173.324997,"eighty":249.116107,"marketCap":3384504988.78},{"date":"2026-08-07","current":-543.110083,"twenty":-431.380818,"median":173.121803,"eighty":248.587668,"marketCap":3869659340.88},{"date":"2026-08-14","current":-563.285348,"twenty":-444.416873,"median":172.850024,"eighty":247.242146,"marketCap":4013408103.64},{"date":"2026-08-21","current":112.812357,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"marketCap":3778875522.96}],"updateTime":1787459586819},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653428732","title":"Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653428732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653428732?lang=en_us&edition=fundamental","pubTime":"2026-07-21 08:35","pubTimestamp":1784594126,"startTime":"0","endTime":"0","summary":"Bell Potter analyst John Hester maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$19.00. Hester covers the Healthc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bell-potter-sticks-to-its-buy-rating-for-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bell-potter-sticks-to-its-buy-rating-for-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","TLPPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653416162","title":"Telix Pharmaceuticals Posts Higher Q2 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2653416162","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653416162?lang=en_us&edition=fundamental","pubTime":"2026-07-21 07:09","pubTimestamp":1784588953,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  reported second-quarter revenue rose 21% to $247 million due to strong sale of precision medicine category, according to a Tuesday filing with the Australian bourse.The company expects fiscal 2026 revenue and other income to be more than $1 billion, with income tracking in line with the upper end of outlook of $950 million to $970 million.It increased its fiscal 2026 research and development expenditure outlook to $230 million to $270 million from prior range of $200 million to$240 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653246410","title":"Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653246410","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653246410?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:00","pubTimestamp":1784581200,"startTime":"0","endTime":"0","summary":"First patient dosed in Phase 3 LUTEON1 trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC).LUTEON is the first Phase 3 study of a CAIX2-targeted radiopharmaceut","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/20/3330128/0/en/Telix-Doses-First-Patient-in-Phase-3-LUTEON-Trial-of-TLX250-Tx-for-Renal-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4139","BK4543","TLX","BK4141","ASX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652250486","title":"3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2652250486","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652250486?lang=en_us&edition=fundamental","pubTime":"2026-07-20 03:20","pubTimestamp":1784488812,"startTime":"0","endTime":"0","summary":"With inflation readings softening in several major economies, bond yields pulling back from recent highs and energy prices back in focus, many investors are looking for growth stories where management has real skin in the game. The Fast Growing Stocks With High Insider Ownership screener targets companies that combine strong growth potential with leadership teams that are publicly optimistic about the outlook. In this article, you will see three stocks from that screener that stand out on...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","TLX","IMLC.AU","E200.AU","XAO.AU","QFN.AU","IOZ.AU","BK7067","IIGF.AU","BEAR.AU","BBOZ.AU","GEAR.AU","XKO.AU","STW.AU","SLF.AU","OZR.AU","VAS.AU","VAP.AU","ZYAU.AU","GIVE.AU","EIGA.AU","XJO.AU","BK7104","PDI.AU","OZF.AU","QRE.AU","TLX.AU","DACE.AU","BK7145","GLF.AU","IISV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652402632","title":"RBC Downgrades Telix Pharmaceuticals to Sector Perform From Outperform, Keeps AU$18 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402632","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652402632?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:26","pubTimestamp":1784283964,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals' (TLX) Australian stock has an average rating of buy and mean price target of AU$25.08, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652847265","title":"3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction","url":"https://stock-news.laohu8.com/highlight/detail?id=2652847265","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652847265?lang=en_us&edition=fundamental","pubTime":"2026-07-17 12:57","pubTimestamp":1784264261,"startTime":"0","endTime":"0","summary":"With growth signals mixed across major economies and central banks pulling policy in different directions, many investors are looking for companies where management and outside analysts are broadly aligned on the outlook. That is exactly what the Fast Growing Stocks With High Insider Ownership screener focuses on, highlighting businesses with strong growth potential where insiders have meaningful skin in the game. This combination can help you focus on opportunities backed by both internal...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-australian-growth-stocks-where-insider-ownership-signals-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-australian-growth-stocks-where-insider-ownership-signals-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XAO.AU","BK7145","IOZ.AU","BK7067","QRE.AU","IMLC.AU","VAS.AU","ZYAU.AU","OZR.AU","BK4139","QFN.AU","EIGA.AU","BK7104","E200.AU","BBOZ.AU","GEAR.AU","XKO.AU","IIGF.AU","GLF.AU","TLX.AU","SLF.AU","XJO.AU","PDI.AU","BEAR.AU","IISV.AU","TLX","STW.AU","DACE.AU","OZF.AU","GIVE.AU","VAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652473490","title":"Telix Pharmaceuticals Completes Phase Three Enrollment for Prostate Cancer Imaging Study in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2652473490","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652473490?lang=en_us&edition=fundamental","pubTime":"2026-07-17 08:45","pubTimestamp":1784249142,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  has completed enrollment of 105 patients in its phase three registration study of TLX591-Px, a prostate cancer imaging agent, in Japan, according to a Friday statement by the company.The study will generate clinical data to support a new drug application submission to Japan's Pharmaceuticals and Medical Devices Agency, seeking approval for the use of the product in detecting metastatic lesions in patients with recurrent prostate cancer.The company's shares fell 2% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK4139","TLX.AU","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651916490","title":"Telix Pharmaceuticals Opens Radiopharmaceutical Research, Manufacturing, Treatment Facility in Melbourne","url":"https://stock-news.laohu8.com/highlight/detail?id=2651916490","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651916490?lang=en_us&edition=fundamental","pubTime":"2026-07-16 10:53","pubTimestamp":1784170381,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) opened a multi-million dollar radiopharmaceutical research, manufacturing, and treatment facility in Melbourne, described as a \"first-of-its-kind\" Australian purpose-bu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","TLX","BK4139","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651973204","title":"3 ASX Growth Stocks Backed By Insiders That Could Reward Patient Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651973204","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651973204?lang=en_us&edition=fundamental","pubTime":"2026-07-16 07:39","pubTimestamp":1784158745,"startTime":"0","endTime":"0","summary":"With inflation pressures moving differently across regions and interest rate expectations constantly in focus, many investors are looking for companies where both analysts and insiders see room for growth. The Fast Growing Stocks With High Insider Ownership screener targets exactly that. It highlights businesses that pair strong growth potential with management teams that have meaningful skin in the game. This combination can help align your interests with those running the company. In this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-asx-growth-stocks-backed-by-insiders-that-could-reward-pat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-asx-growth-stocks-backed-by-insiders-that-could-reward-pat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK4211","BK4139","BK7095","TLX","PDI.AU","LIN.AU","BK7067","BK7104","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651967224","title":"Telix Reports First Patients Dosing in Prostate Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651967224","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651967224?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:58","pubTimestamp":1784149110,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said late Wednesday the first patients with metastatic hormone-sensitive prostate cancer have been dosed with TLX597-Tx in a phase 2 trial at St Vincent's Hospital in Sydney, Australia.The OPTIMAL-e trial will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on the OPTIMAL-PSMA2 study which recently completed patient enrollment, the firm said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","TLX.AU","BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480576","title":"Citi Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480576?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:35","pubTimestamp":1784075737,"startTime":"0","endTime":"0","summary":"Citi analyst Laura Sutcliffe maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$31.00. According to TipRanks, Sutcl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-their-buy-rating-for-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-their-buy-rating-for-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPPF","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651748293","title":"Citi Sees Positive Catalysts for Telix Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2651748293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651748293?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:06","pubTimestamp":1784070360,"startTime":"0","endTime":"0","summary":"2305 GMT - Telix Pharmaceuticals' stock looks a good bet to outperform over the next month, suggests Citi. That's despite a 41% rise in its share price since the start of the year. \"We open a positive 30-day catalyst watch on Telix as we think 2Q delivery will be robust and potentially ahead of consensus,\" analyst Laura Sutcliffe says. Citi also sees support for Telix's stock as it approaches the potential resubmission of kidney-cancer imaging agent Zircaix and potential approval and launch of brain-cancer imaging agent Pixclara. It rates Telix at \"buy, high-risk.\"  Dow Jones NewswiresJuly 14, 2026 19:06 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX","BK4139","BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810194","title":"3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651810194?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:28","pubTimestamp":1784060937,"startTime":"0","endTime":"0","summary":"With inflation, energy shocks and shifting interest rate expectations all pulling markets in different directions, many investors are looking for growth stories that management itself is confident enough to own. That is exactly what the Fast Growing Stocks With High Insider Ownership screener is built to highlight by filtering for companies where analysts see solid growth potential and insiders have committed their own capital. This combination can help you focus on businesses where outlook...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-asx-growth-stocks-investors-are-watching-after-sharp-pullb","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-asx-growth-stocks-investors-are-watching-after-sharp-pullb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","TLX.AU","BK7067","ISBC","BK7104","BK4139","PDI.AU","BK7095","TLX","LIN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143971","title":"Telix Stock And Two ASX Growth Picks Backed By Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143971","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143971?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:26","pubTimestamp":1783945618,"startTime":"0","endTime":"0","summary":"With oil prices, global bond yields and inflation expectations all in focus, a lot of attention is on interest rates and how companies handle a more volatile cost of capital. In this setting, many investors are looking at fast growing stocks where insiders hold meaningful stakes, which can help align management with shareholders when conditions are choppy. Our Fast Growing Stocks With High Insider Ownership screener highlights companies where growth expectations from analysts and management...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/telix-stock-and-two-asx-growth-picks-backed-by-insider-owner","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/telix-stock-and-two-asx-growth-picks-backed-by-insider-owner","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4570","PPI","BK7104","LIN.AU","BK4139","BK7095","TLX.AU","BK7067","TLX","PDI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650378150","title":"3 Fast Growing ASX Stocks With High Insider Ownership to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2650378150","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650378150?lang=en_us&edition=fundamental","pubTime":"2026-07-12 12:26","pubTimestamp":1783830409,"startTime":"0","endTime":"0","summary":"Fast growing stocks with high insider ownership can be especially interesting when inflation trends, interest rate expectations and geopolitical tensions are all pulling markets in different directions. With investors watching oil prices, bond yields and earnings reports so closely, this screener focuses on companies where growth is a key part of the story and management has significant skin in the game. That combination can appeal if you want exposure to growth, but also care about alignment...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-fast-growing-asx-stocks-with-high-insider-ownership-to-wat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/3-fast-growing-asx-stocks-with-high-insider-ownership-to-wat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","BK7067","BK4139","LIN.AU","TLX.AU","TLX","PDI.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650708329","title":"Telix trims potential dilution as conditional share rights lapse","url":"https://stock-news.laohu8.com/highlight/detail?id=2650708329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650708329?lang=en_us&edition=fundamental","pubTime":"2026-07-10 06:51","pubTimestamp":1783637480,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an announcement. Telix Pharmaceuticals has reported the lapse of several tranches of share rights...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-trims-potential-dilution-as-conditional-share-rights-lapse?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-trims-potential-dilution-as-conditional-share-rights-lapse?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650970837","title":"Telix Pharmaceuticals Issues New Shares After Conversion of Unquoted Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2650970837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650970837?lang=en_us&edition=fundamental","pubTime":"2026-07-10 06:51","pubTimestamp":1783637460,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an announcement. Telix Pharmaceuticals has reported the issue of 83,750 new ordinary fully paid s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-issues-new-shares-after-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-issues-new-shares-after-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650977024","title":"Telix Seeks ASX Quotation for Additional Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650977024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650977024?lang=en_us&edition=fundamental","pubTime":"2026-07-10 06:50","pubTimestamp":1783637450,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has issued an announcement. Telix Pharmaceuticals has applied to the ASX for quotation of 405,463 ordinary full...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-seeks-asx-quotation-for-additional-ordinary-shares-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-seeks-asx-quotation-for-additional-ordinary-shares-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650190382","title":"Fast Growing Australian Stocks Where Insider Ownership Signals Real Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2650190382","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650190382?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:44","pubTimestamp":1783629853,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and energy prices pulling markets in different directions, many investors are looking for companies where growth plans and insider incentives are clearly aligned. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses that analysts and management teams both view positively, and where insiders hold meaningful stakes in the stock. That combination can help you focus on companies where growth is a central priority and leadership is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/fast-growing-australian-stocks-where-insider-ownership-signa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/predictive-discovery-shares/news/fast-growing-australian-stocks-where-insider-ownership-signa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IIGF.AU","E200.AU","TLX","BBOZ.AU","BK4139","GEAR.AU","BEAR.AU","EIGA.AU","VAS.AU","PDI.AU","BK7104","DACE.AU","GIVE.AU","TLX.AU","LIN.AU","STW.AU","QRE.AU","BK7067","IOZ.AU","XAO.AU","IMLC.AU","OZF.AU","SLF.AU","BK7095","VAP.AU","IISV.AU","ZYAU.AU","XKO.AU","XJO.AU","OZR.AU","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955071","title":"Champion Iron Stock And 2 Fast Growing Insider Owned Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955071","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649955071?lang=en_us&edition=fundamental","pubTime":"2026-07-08 06:31","pubTimestamp":1783463508,"startTime":"0","endTime":"0","summary":"With inflation expectations tied to oil prices, central banks weighing rate moves and growth signals mixed across major economies, many investors are looking for companies where management is clearly aligned with shareholders and focused on expansion. That is the idea behind the Fast Growing Stocks With High Insider Ownership screener, which highlights businesses that combine growth potential with management teams that hold meaningful stakes in their own stock. This article walks through...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cia/champion-iron-shares/news/champion-iron-stock-and-2-fast-growing-insider-owned-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cia/champion-iron-shares/news/champion-iron-stock-and-2-fast-growing-insider-owned-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LIN.AU","GUNR","TLX","BK7067","BK4139","BK7095","BK4585","CIA.AU","BK7129","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":199,"code":"91000000","status":"200"}]}}